Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 5612

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.30, p 0.436). This receipt's hash covers every field on it, plus the hash of receipt 5611, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 5612
    21 Oct 2026, 18:56 UTC

    PIM2

    dopamine neurons, braak

    predictionPIM2 in dopamine neurons tracks Braak Lewy-body stage

    registereded436006bb5211b2

    discovery-0.30 p=0.436 n=9

    replication-0.18 p=0.635 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.30, p 0.436)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    c4e8c9fd4ce48f0635af473e…
    follows 2b36015f9986…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 5612: PIM2 in dopamine neurons, braak

power
full sample -0.33 (p 0.188, n 18), 95% CI -0.69 to +0.17. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.36 (p 0.142, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.46 (p 0.055, n 18). could be the mix.
skeptic
leave-one-out range -0.40 to -0.24, sign flips 0; without severely affected donors -0.33 (p 0.188, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for PIM2 in dopamine neurons.

case closed: nothing better to follow up.